Endothelial Keratoplasty of the Descemet Membrane in Uveal Melanoma Patients Following Radiation Treatment - Scorecard - MDSpire

Endothelial Keratoplasty of the Descemet Membrane in Uveal Melanoma Patients Following Radiation Treatment

  • By

  • Anna-Karina B. Maier

  • Dhoksina Papa

  • Aline Riechardt

  • Jens Heufelder

  • Oliver Zeitz

  • Antonia M. Joussen

  • Tina Dietrich-Ntoukas

  • April 2, 2026

  • 0 min

Share

Clinical Scorecard: Endothelial Keratoplasty of the Descemet Membrane in Uveal Melanoma Patients Following Radiation Treatment

At a Glance

CategoryDetail
Condition
Key MechanismsCorneal endothelial disorders treated with Descemet membrane endothelial keratoplasty (DMEK) post-radiation therapy, including Fuchs endothelial corneal dystrophy and bullous keratopathy.
Target Population
Care Setting

Key Highlights

  • Visual acuity improved post-DMEK surgery at 3, 12, and 24 months, with specific metrics to be included.

Guideline-Based Recommendations

Diagnosis

    Management

    • DMEK surgery indicated for corneal endothelial disorders post-radiation, with detailed management strategies for secondary glaucoma.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        DMEK is effective for visual rehabilitation but may have less favorable outcomes in complex cases, defined as those with multiple prior ocular surgeries or significant comorbidities.

        Clinical Best Practices

        • Monitor for complications such as graft rejection and IOP elevation postoperatively, with specific follow-up intervals and assessments.

        References

        Original Source(s)

        Related Content